technology
Personalized mRNA cancer vaccine cut melanoma death, recurrence by 42%
arstechnica.com • 22 Oct 2026, 22:12
Markers released top-line results today after previously reporting the trial succeeded.
Les originalartikkelen
Mere fra arstechnica.com
- Switch 2 jailbreak gives hackers new ways to run homebrew and mod games
- Latest estimate for Starship launches required to support a Moon landing? 22.
- Comcast loses more customers, claims other ISPs' cheap prices are "irrational"
- Disgraced eMudhra drops out of TLS business following certificate debacle